Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDNewAmsterdam Pharma Company N.V. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2024 | Q3 2024 | -$0.18 | $29.11 M | |||
| 08/07/2024 | Q2 2024 | -$0.38 | $2.13 M | |||
| 05/08/2024 | Q1 2024 | -$0.98 | $1.30 M | |||
| 02/28/2024 | Q4 2023 | -$0.52 | $1.59 M | |||
| 09/29/2023 | Q3 2023 | -$0.56 | $1.88 M | |||
| 08/07/2023 | Q2 2023 | -$0.43 | $1.57 M | |||
| 08/07/2023 | Q1 2023 | -$0.47 | $7.96 M | |||
| 03/31/2023 | Q4 2022 | -$24.19 | $1.38 M | |||
| 11/28/2022 | Q3 2022 | -$23.19 | $5.62 M | |||
| 06/28/2022 | Q2 2022 | $0.75 | $46.75 M | |||
| 03/29/2022 | Q1 2022 | $0.75 | $46.75 M | |||
| 12/30/2021 | Q4 2021 | -$1.73 | $0 | |||
| 09/29/2021 | Q3 2021 | -$0.82 | $0 | |||
| 06/29/2021 | Q2 2021 | -$0.43 | $0 | |||
| 03/30/2021 | Q1 2021 | -$0.43 | $0 | |||
| 12/30/2020 | Q4 2020 | $0.00 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.02 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.02 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.02 | $0 |
NewAmsterdam Pharma Company N.V. Earnings: FAQ's
How can I listen to NewAmsterdam Pharma Company N.V.'s earnings conference
call?
The conference call for NewAmsterdam Pharma Company N.V.'s latest earnings report can be listened to online.
How can I read NewAmsterdam Pharma Company N.V.'s conference call transcript?
The conference call transcript for NewAmsterdam Pharma Company N.V.'s latest earnings report can be read online.
How much revenue does NewAmsterdam Pharma Company N.V. generate each year?
NewAmsterdam Pharma Company N.V. (:NAMSW) has a recorded annual revenue of $12.76 M.
How much profit does NewAmsterdam Pharma Company N.V. generate each year?
NewAmsterdam Pharma Company N.V. (:NAMSW) has a recorded net income of $12.76 M. NewAmsterdam Pharma Company N.V. has generated $-2.15 earnings per share over the last four quarters.
What is NewAmsterdam Pharma Company N.V.'s price-to-earnings ratio?
NewAmsterdam Pharma Company N.V. (:NAMSW) has a price-to-earnings ratio of -13.54 and price/earnings-to-growth ratio is -0.87.